119 related articles for article (PubMed ID: 38124378)
1. The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y; Kanemura N; Nakamura N; Ikoma Y; Yamaguchi K; Takada E; Shibata Y; Lee S; Fujita K; Morishita T; Matsumoto T; Nakamura H; Kitagawa J; Kasahara S; Hara T; Tsurumi H; Shimizu M
Leuk Lymphoma; 2024 Mar; 65(3):339-345. PubMed ID: 38124378
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.
Matsukawa T; Suto K; Kanaya M; Izumiyama K; Minauchi K; Yoshida S; Oda H; Miyagishima T; Mori A; Ota S; Hashimoto D; Teshima T;
Ann Hematol; 2020 Dec; 99(12):2859-2868. PubMed ID: 32970194
[TBL] [Abstract][Full Text] [Related]
3. The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients.
Baysal M; Bas V; Demirci U; Gulsaran SK; Umit E; Kirkizlar HO; Demir AM
Niger J Clin Pract; 2021 Aug; 24(8):1194-1199. PubMed ID: 34397030
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma.
Nagata A; Kanemasa Y; Sasaki Y; Nakamura S; Okuya T; Funasaka C; Kageyama A; Shimoyama T; Omuro Y
Hematol Oncol; 2020 Aug; 38(3):309-317. PubMed ID: 32223021
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma.
Nakamura N; Kanemura N; Lee S; Fujita K; Morishita T; Takada E; Shibata Y; Kasahara S; Goto H; Fukuno K; Hara T; Yamada T; Sawada M; Tsurumi H; Shimizu M
Leuk Lymphoma; 2022 Jun; 63(6):1323-1330. PubMed ID: 34965828
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma.
Go SI; Choi BH; Park MJ; Park S; Kang MH; Kim HG; Kang JH; Jeong EJ; Lee GW
BMC Cancer; 2023 Nov; 23(1):1071. PubMed ID: 37932700
[TBL] [Abstract][Full Text] [Related]
7. Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
Akgün Çağlıyan G; Hacıoğlu S; Ünver Koluman B; İlkkılıç K; Nar R; Başer MN; Bozdemir A; Şenol H; Şen Türk N; Erol V; Yılıdırım O; Çağlıyan Ö; Güler N
Turk J Med Sci; 2021 Aug; 51(4):2112-2119. PubMed ID: 33957727
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of controlling nutritional status (CONUT) score-based nomogram on extranodal natural killer/T cell lymphoma patients.
Zhang S; Sun C; Chen X; Li D; Hu L; Zhang M; Zhang X; Zhang H; Ye J; Wang L; Jia T; Zhu T; Miao Y; Wang C; Wang L; Yan D; Shen Z; Sang W
Ann Hematol; 2023 Jun; 102(6):1433-1442. PubMed ID: 37074377
[TBL] [Abstract][Full Text] [Related]
9. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
10. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
11. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group.
Ma S; Zhang B; Lu T; Li D; Li T; Shen Z; He C; Wang Y; Li B; Zhang H; Gu W; Wang C; Ye J; Zhu T; Miao Y; Wang L; Huang S; Liu Q; Sang W;
Cancer; 2022 Oct; 128(19):3487-3494. PubMed ID: 35932292
[TBL] [Abstract][Full Text] [Related]
12. Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study.
Chuang TM; Liu YC; Hsiao HH; Wang HC; Du JS; Yeh TJ; Gau YC; Ke YL; Yang CI; Lee CP; Hsu CM; Cho SF
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579119
[TBL] [Abstract][Full Text] [Related]
13. Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Yagi Y; Kanemasa Y; Sasaki Y; Goto S; Yamamura Y; Ishimine K; Hayashi Y; Mino M; Ohigashi A; Morita Y; Tamura T; Nakamura S; Okuya T; Shimoyama T
Ann Hematol; 2023 Jun; 102(6):1485-1500. PubMed ID: 37115298
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma.
Liu T; Hu R; Lv J; Luo Q; Xu L; Wang C; Liu J; Yang Z; Xu L; Liu Y
Front Nutr; 2022; 9():1050139. PubMed ID: 36438738
[TBL] [Abstract][Full Text] [Related]
15. Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma.
Kanemasa Y; Shimoyama T; Sasaki Y; Hishima T; Omuro Y
Ann Hematol; 2018 Jun; 97(6):999-1007. PubMed ID: 29427185
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of controlling nutritional status score in hematological malignancies.
Zhang Y; Chen Q; Lu C; Yu L
Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
[TBL] [Abstract][Full Text] [Related]
17. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
18. Prognostic effect of preoperative Controlling Nutritional Status score in patients with locally advanced rectal cancer: A two-center, retrospective study.
Lu S; Chen Z; Peng R; Zhang Q; Wang Y; Li X; Qu R; Zhou X; Fu W; Sun T; Wang H
Nutrition; 2023 Aug; 112():112078. PubMed ID: 37267656
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
Huang H; Fan L; Fu D; Lin Q; Shen J
Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
